Results 191 to 200 of about 2,340,035 (348)

Phlyctenular keratoconjunctivitis with viral triggers. [PDF]

open access: yesWorld J Virol
Capobianco M   +9 more
europepmc   +1 more source

Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges

open access: yesBritish Journal of Pharmacology, EarlyView.
This review systematically outlines the mechanisms underlying tumour immunotherapy resistance and elucidates the role of natural products in enhancing therapeutic efficacy as immunomodulatory adjuvants. Abstract Immunotherapy has emerged as a clinically pivotal approach in cancer treatment, but its application remains limited to a small subset of ...
Rao Hu   +6 more
wiley   +1 more source

Hypersensitivity Reactions to Benzodiazepines Used for Perioperative Premedication: A Narrative Review. [PDF]

open access: yesPharmaceuticals (Basel)
Gąsiorowska J   +7 more
europepmc   +1 more source

The Role for Decorin in Delayed-Type Hypersensitivity

open access: yesJournal of Immunology, 2011
D. Seidler   +9 more
semanticscholar   +1 more source

Cancer pain: current practice and emerging targets

open access: yesBritish Journal of Pharmacology, EarlyView.
Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye   +5 more
wiley   +1 more source

Immediate and delayed hypersensitivity to biologicals in children-A practical approach: An EAACI task force report. [PDF]

open access: yesPediatr Allergy Immunol
Mori F   +13 more
europepmc   +1 more source

Delayed drug hypersensitivity: models of T-cell stimulation.

open access: yesBritish Journal of Clinical Pharmacology, 2011
Jacqueline Adam   +2 more
semanticscholar   +1 more source

Contact sensitisers activate keratinocytes and induce cytotoxicity via Transient Receptor Potential Ankyrin 1 in allergic contact dermatitis

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Allergic contact dermatitis (ACD) is a frequent inflammatory skin disease with limited therapeutic options. While neuronal Transient Receptor Potential Ankyrin 1 (TRPA1) has been implicated in ACD, the role of keratinocyte TRPA1 remains unclear.
Areej Jaber   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy